2Gibson DM,BS J,Bron NJ,et al.Effect of age and gender on pharmacokinetics of atorvastatin in humans[].Journal of Clinical Pharmacology.1996
3Nawrocki JW,Weiss SR,Davidson MH,et al.Reduction of LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor[].Arteriosclerosis and Thrombosis.1995
4Marais AD,Firth JC,Bateman ME,et al.Atorvastatin: an effective lipid-modifying agent in familial hypercholesterolemia[].Arteriosclerosis and Thrombosis.1997
5Bakker-Arkema RG,Davidson MH,Goldstein RJ,et al.Efficacy and safety of a new HMG-CoA reductase inhibitor, atorvastatin, in patients with hypertriglyceridemia[].The Journal of The American Medical Association.1996
6Dart A,Jerums G,Nicholson G,et al.A multicenter, double-blind,one-year study comparing safety and efficacy of atorvastatin versus simvastatin in patients with hypercholesterolemia[].The American Journal of Cardiology.1997
7Bertolini S,Bon GB,Campbell LM,et al.Efficacy and safety of atorvastatin compared to pravastatin in patients with hypercholesterolemia[].Atherosclerosis.1997
8Davidson M,Mckenney J,Stein E,et al.Comparison of one-year efficacy and safety of atorvastatin-versus-lovastatin in primary hypercholesterolemia; Atorvastatin Study Group 1[].The American Journal of Cardiology.1997
9Jones P,Kafonek S,Laurora I,et al.Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (The CURVES Study)[].The American Journal of Cardiology.1998
10Brown AS,Bakker-Arkema RG,Yellen L,et al.Treating patients with documented atherosclerosis to national cholesterol education program-recommended low-density-lipoprotein cholesterol goals with atorvastatin,fluvastatin, lovastatin and simvastatin[].Journal of the American College of Cardiology.1998
2Vershuren WM,Jacobs DR,Bloemberg BPM,et al. Serum total cholesterol and long-term coronary heart disease mortailty in different culture: twenty-five-year follow-up of the seven countries study. JAMA, 1995,274:131-136.
3Brown MS,Goldsein JL.Areceptor mediated pathway for cholesterol homeostasis.Science,1986,232:34—47.
